Abbasian, Mohammad Hadi, Ansarinejad, Nafiseh, Ramim, Tayeb, Fardad, Farshid, Abbasi, Bahareh. (1401). SLC19A1 and Thymidylate Synthase Polymorphisms do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen. سامانه مدیریت نشریات علمی, (), -. doi: 10.30476/mejc.2022.89424.1600
Mohammad Hadi Abbasian; Nafiseh Ansarinejad; Tayeb Ramim; Farshid Fardad; Bahareh Abbasi. "SLC19A1 and Thymidylate Synthase Polymorphisms do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen". سامانه مدیریت نشریات علمی, , , 1401, -. doi: 10.30476/mejc.2022.89424.1600
Abbasian, Mohammad Hadi, Ansarinejad, Nafiseh, Ramim, Tayeb, Fardad, Farshid, Abbasi, Bahareh. (1401). 'SLC19A1 and Thymidylate Synthase Polymorphisms do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen', سامانه مدیریت نشریات علمی, (), pp. -. doi: 10.30476/mejc.2022.89424.1600
Abbasian, Mohammad Hadi, Ansarinejad, Nafiseh, Ramim, Tayeb, Fardad, Farshid, Abbasi, Bahareh. SLC19A1 and Thymidylate Synthase Polymorphisms do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen. سامانه مدیریت نشریات علمی, 1401; (): -. doi: 10.30476/mejc.2022.89424.1600


Contact Us | Help & Support | Site Map

Journal Management System. Designed by sinaweb.